NO20042074L - Makrolider inneholdende farmasoytiske sammensetninger - Google Patents

Makrolider inneholdende farmasoytiske sammensetninger

Info

Publication number: NO20042074L
Authority: NO; Norway
Prior art keywords: pharmaceutical compositions; containing pharmaceutical; macrolides containing; macrolides; compositions
Prior art date: 2001-10-23

Application number

NO20042074A

Other languages

English (en)

Norwegian (no)

Inventor

Josef Gottried Meingassner

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-23

Filing date

2004-05-19

Publication date

2004-05-19

2001-11-14 Priority claimed from GB0127341A external-priority patent/GB0127341D0/en

2004-05-19 Application filed by Novartis Ag filed Critical Novartis Ag

2004-05-19 Publication of NO20042074L publication Critical patent/NO20042074L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Biomedical Technology (AREA)
Transplantation (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

NO20042074A 2001-10-23 2004-05-19 Makrolider inneholdende farmasoytiske sammensetninger NO20042074L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB0125443.2A GB0125443D0 (en)	2001-10-23	2001-10-23	Organic Compounds
GB0127341A GB0127341D0 (en)	2001-11-14	2001-11-14	Organic compounds
PCT/EP2002/011799 WO2003035068A1 (fr)	2001-10-23	2002-10-22	Compositions pharmaceutiques contenant des macrolides

Publications (1)

Publication Number	Publication Date
NO20042074L true NO20042074L (no)	2004-05-19

Family

ID=26246689

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20042074A NO20042074L (no)	2001-10-23	2004-05-19	Makrolider inneholdende farmasoytiske sammensetninger

Country Status (19)

Country	Link
US (1)	US7259170B2 (fr)
EP (1)	EP1439838A1 (fr)
JP (1)	JP2005509634A (fr)
KR (2)	KR100978971B1 (fr)
CN (1)	CN1307993C (fr)
AU (1)	AU2002346859C1 (fr)
BR (1)	BR0213463A (fr)
CA (1)	CA2458690C (fr)
EC (1)	ECSP045086A (fr)
GB (1)	GB0125443D0 (fr)
HU (1)	HUP0402108A3 (fr)
IL (1)	IL160973A0 (fr)
MX (1)	MXPA04003738A (fr)
NO (1)	NO20042074L (fr)
NZ (1)	NZ532412A (fr)
PL (1)	PL368533A1 (fr)
RU (1)	RU2321402C2 (fr)
WO (1)	WO2003035068A1 (fr)
ZA (1)	ZA200401711B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002089796A2 (fr) *	2001-05-09	2002-11-14	Novartis Ag	Procedes d'immunomodulation selective
CA2473461C (fr)	2002-01-11	2011-11-01	Sankyo Company, Limited	Derive d'amino-alcool ou derive d'acide phosphonique et composition medicamenteuse les contenant
GB0307867D0 (en) *	2003-04-04	2003-05-14	Novartis Ag	Pharmaceutical composition
RU2332212C2 (ru)	2004-02-24	2008-08-27	Санкио Компани, Лимитед	Аминоспирт

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0349061B1 (fr)	1988-06-29	1995-03-29	Merck & Co. Inc.	Agent immuno-suppresseur
ATE126803T1 (de) *	1989-11-09	1995-09-15	Sandoz Ag	Heteroatome enthaltende tricyclische verbindungen.
US5352671A (en) *	1989-11-09	1994-10-04	Sandoz Ltd.	Heteroatoms-containing tricyclic compounds
GB2252041A (en)	1991-01-23	1992-07-29	Fujisawa Pharmaceutical Co	Use of macrolide compounds in treatment of autoimmune myocarditis
CA2106483A1 (fr) *	1991-03-19	1992-09-20	Vithal J. Rajadhyaksha	Compositions a base de derives d'aminoalcool et methode permettant d'ameliorer la penetration membranaire
US5247076A (en) *	1991-09-09	1993-09-21	Merck & Co., Inc.	Imidazolidyl macrolides having immunosuppressive activity
GB9203636D0 (en) *	1992-02-19	1992-04-08	Lucas Ind Plc	Fuel pumping apparatus
JP2579602B2 (ja)	1992-10-21	1997-02-05	吉富製薬株式会社	２−アミノ−１，３−プロパンジオール化合物および免疫抑制剤
WO1994021642A1 (fr)	1993-03-17	1994-09-29	Abbott Laboratories	IMMUNOREGULATEURS A l'AMIDE MACROCYCLIQUE ET A L'UREE
US5590460A (en) *	1994-07-19	1997-01-07	Tessera, Inc.	Method of making multilayer circuit
DE69524962D1 (de) *	1994-08-22	2002-02-14	Welfide Corp	Benzolderivate und deren medizinische verwendung
GB9521322D0 (en)	1995-10-17	1995-12-20	Sandoz Ltd	Organic compounds
JPH11209277A (ja)	1998-01-19	1999-08-03	Yoshitomi Pharmaceut Ind Ltd	医薬組成物
GB9624038D0 (en)	1996-11-19	1997-01-08	Sandoz Ltd	Organic compounds
IL155065A (en)	1997-04-04	2004-01-04	Mitsubishi Pharma Corp	History - 2 Aminopropene - 1, 3 - Diol and Pharmaceutical Preparations Containing Them
GB9713730D0 (en) *	1997-06-30	1997-09-03	Ciba Geigy Ag	Organic compounds
JP4627356B2 (ja) *	1999-06-30	2011-02-09	昭松森	ウイルス性心筋炎の予防または治療薬剤
GB0003932D0 (en)	2000-02-18	2000-04-12	Novartis Ag	Pharmaceutical compositions
DE60130032D1 (de)	2000-12-22	2007-09-27	Avantec Vascular Corp	Vorrichtung zur Abgabe von therapeutischen Wirkstoffen

2001
- 2001-10-23 GB GBGB0125443.2A patent/GB0125443D0/en not_active Ceased
2002
- 2002-10-22 KR KR1020047005958A patent/KR100978971B1/ko not_active Expired - Fee Related
- 2002-10-22 CN CNB028211588A patent/CN1307993C/zh not_active Expired - Fee Related
- 2002-10-22 MX MXPA04003738A patent/MXPA04003738A/es active IP Right Grant
- 2002-10-22 BR BR0213463-2A patent/BR0213463A/pt not_active IP Right Cessation
- 2002-10-22 NZ NZ532412A patent/NZ532412A/en unknown
- 2002-10-22 JP JP2003537635A patent/JP2005509634A/ja active Pending
- 2002-10-22 CA CA2458690A patent/CA2458690C/fr not_active Expired - Fee Related
- 2002-10-22 US US10/492,439 patent/US7259170B2/en not_active Expired - Fee Related
- 2002-10-22 KR KR1020097021354A patent/KR20090114483A/ko not_active Ceased
- 2002-10-22 AU AU2002346859A patent/AU2002346859C1/en not_active Ceased
- 2002-10-22 EP EP02782975A patent/EP1439838A1/fr not_active Withdrawn
- 2002-10-22 HU HU0402108A patent/HUP0402108A3/hu unknown
- 2002-10-22 PL PL02368533A patent/PL368533A1/xx not_active Application Discontinuation
- 2002-10-22 WO PCT/EP2002/011799 patent/WO2003035068A1/fr not_active Ceased
- 2002-10-22 IL IL16097302A patent/IL160973A0/xx unknown
- 2002-10-22 RU RU2004116067/15A patent/RU2321402C2/ru not_active IP Right Cessation
2004
- 2004-03-02 ZA ZA200401711A patent/ZA200401711B/en unknown
- 2004-04-23 EC EC2004005086A patent/ECSP045086A/es unknown
- 2004-05-19 NO NO20042074A patent/NO20042074L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
US7259170B2 (en)	2007-08-21
BR0213463A (pt)	2004-11-09
RU2004116067A (ru)	2005-04-20
NZ532412A (en)	2006-01-27
ZA200401711B (en)	2004-10-21
CA2458690A1 (fr)	2003-05-01
AU2002346859C1 (en)	2008-07-10
IL160973A0 (en)	2004-08-31
ECSP045086A (es)	2004-06-28
CN1307993C (zh)	2007-04-04
KR20040052250A (ko)	2004-06-22
US20040192716A1 (en)	2004-09-30
AU2002346859B2 (en)	2006-03-02
JP2005509634A (ja)	2005-04-14
HUP0402108A2 (hu)	2005-02-28
PL368533A1 (en)	2005-04-04
CA2458690C (fr)	2011-01-25
GB0125443D0 (en)	2001-12-12
WO2003035068A1 (fr)	2003-05-01
HUP0402108A3 (en)	2008-02-28
KR100978971B1 (ko)	2010-08-30
EP1439838A1 (fr)	2004-07-28
CN1575173A (zh)	2005-02-02
KR20090114483A (ko)	2009-11-03
MXPA04003738A (es)	2004-07-23
RU2321402C2 (ru)	2008-04-10

Publication	Publication Date	Title
FI20011478L (fi)	2003-01-06	Farmaseuttinen koostumus
AR028204A1 (es)	2003-04-30	Composiciones farmaceuticas electrohiladas
FI20105657L (fi)	2010-06-10	Farmaseuttisia koostumuksia
ITMI20010748A0 (it)	2001-04-06	Composizioni farmaceutiche
DK1524266T3 (da)	2007-06-25	Farmaceutisk sammensætning
NO20033384L (no)	2003-09-25	Farmasoytisk formulering
NO20033556L (no)	2003-10-09	Farmasöytiske formuleringer
NO20033785L (no)	2003-10-24	Farmasöytisk formulering
AT7729U3 (de)	2006-01-15	Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat
IS7051A (is)	2003-11-26	Lyfjasamsetningar
DK1458377T3 (da)	2006-06-12	Farmaceutiske sammensætninger indeholdende tegaserod
NO20035627D0 (no)	2003-12-15	Farmasöytisk formulering
NO20026123L (no)	2003-02-18	Farmasöytiske sammensetninger
FI20022128L (fi)	2003-06-06	Farmaseuttinen koostumus
DK1425005T3 (da)	2006-09-04	Farmaceutisk sammensætning indeholdende lumiracoxib
NO20031095D0 (no)	2003-03-10	Farmasöytiske sammensetninger
ATE350016T1 (de)	2007-01-15	Bicalutamid enthaltende pharmazeutische zusammensetzung
NO20041485L (no)	2004-04-13	Farmasoytisk formulering omfattende (R)-bicalutamid
NO20042074L (no)	2004-05-19	Makrolider inneholdende farmasoytiske sammensetninger
ATE350029T1 (de)	2007-01-15	Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain
EE200300465A (et)	2003-12-15	Püridoindolooni derivaatidel põhinevad farmatseutilised kompositsioonid
NO20033073L (no)	2003-07-04	Farmasöytisk sammensetning inneholdende citalopram
EE200200689A (et)	2004-06-15	Ravimkoostised
EP1413314A4 (fr)	2004-12-22	Composition medicinale
FI5468U1 (fi)	2002-07-30	Farmaseuttinen koostumus

Legal Events

Date	Code	Title	Description
2010-05-31	FC2A	Withdrawal, rejection or dismissal of laid open patent application